Has Khashayar Farsad, MD received payments from drug or device companies?

Yes. Drug and device makers reported $54,545 in general payments to Khashayar Farsad, MD across 53 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Khashayar Farsad, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Khashayar Farsad, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Khashayar Farsad, MD

Vascular & Interventional Radiology · Portland, ORNPI 1376578609

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $46,739 of the $54,545 with a category attached, or 85.7%. 14 manufacturers reported payments, led by Medical Device Business Services, Inc. at 27.7% of the total. Reporting peaked in 2019 at $15,541 and has fallen 71.7% since, to $4,396 in 2025. Among vascular & interventional radiology clinicians in OR with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$54,545in general payments, 2019–2025

Across 53 payments — averaging $1029.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Medical Device Business Services, Inc.$15K
Baylis Medical Technologies Inc.$10K
Biocompatibles, Inc.$7K
Guerbet LLC$6K
Genentech USA, Inc.$4K
Cook Incorporated$4K
plus $9K from 8 others

$1,399,370in research payments, 2019–2025

Across 102 payments — averaging $13,719 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Merck$1.1M
Guerbet LLC$142K
AstraZeneca$74K
Medtronic$43K
Bard Peripheral Vascular, Inc.$16K
Dova Pharmaceuticals$6K
plus $2K from 1 others

What the payments were for

Consulting fees$46,73986%
Travel & lodging$5,30210%
Food & beverage$2,5045%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Medical Device Business Services, Inc.	7	$15,109
Baylis Medical Technologies Inc.	4	$10,113
Biocompatibles, Inc.	2	$6,773
Guerbet LLC	17	$6,139
Genentech USA, Inc.	5	$3,884
Cook Incorporated	5	$3,780
Eisai Inc.	1	$2,520
Dova Pharmaceuticals	2	$2,353
Boston Scientific	2	$1,613
Delcath Systems	2	$1,325
Ethicon Endo-surgery Inc.	1	$600
Cook Medical LLC	2	$185
Bard Peripheral Vascular, Inc.	1	$104
Stryker	2	$48

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Certus 140$10,043
THERASPHERE-BIO$7,485
Lipiodol$5,613
CERTUS 140 MICROWAVE ABLATION SYSTEM$5,017
TECENTRIQ$3,857
Cook Medical Embolization$2,750
LENVIMA$2,520
DOPTELET$2,353
Hepzato Kit$1,325
Tornado$1,030
GENERAL VASCULAR INTERVENTION$900
NeuFlex$600
SEQURE$400
ICAST COVERED STENT SYSTEM, 6MMX22MMX120CM$149
VENOVO$104

How this compares

$54,545 in reported general payments places this provider in the 90th percentile of 73 vascular & interventional radiology providers in Oregon.

See all vascular & interventional radiology providers in Oregon →

Medicare billing

Part B allowed, 2024

$32,159

Medicare patients

Services billed

257

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other vascular & interventional radiology in Portland

Jonathan SteinbergerPortland$391K
Ryan PriestPortland$94K
Mary CostantinoPortland$90K
Jed PetersonPortland$36K
Hasnain HashamPortland$34K
Marc Michael LimPortland$31K
John KaufmanPortland$29K
Masahiro HorikawaPortland$25K
Ryan SchenningPortland$23K
Yilun KoethePortland$23K

See the full list for Oregon →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →